Inhibition of growth factor production and angiogenesis in human cancer cells by ZD1839 (Iressa), a selective epidermal growth factor receptor tyrosine kinase inhibitor - Ciardiello,F.; Caputo,R.; Bianco,R. (Clin Cancer Res, 2001)